Leadbetter M G, Matusik J E
U.S. Food and Drug Administration, Center for Veterinary Medicine, Beltsville, MD 20705.
J AOAC Int. 1993 Mar-Apr;76(2):420-3.
The U.S. Food and Drug Administration sponsored an interlaboratory study of a liquid chromatographic determination with ultraviolet detection of nicarbazin in chicken liver and muscle tissues. The method determined the 4,4'-dinitrocarbanilide (DNC) portion of nicarbazin. The interlaboratory study of the determinative method was successful for nicarbazin at the 4 ppm level. Results showed good reproducibility for the fortified liver and muscle samples. Mean interlaboratory recoveries and percent coefficients of variation at about 4 ppm were 87.1 and 10.9%, respectively, for muscle and 87.4 and 7.5%, respectively, for liver. The interlaboratory analyses of the dosed liver and muscle tissues produced concentration levels similar to those obtained by the sponsor. The confirmatory procedure, which identified DNC in purified tissue extracts, used liquid chromatography-thermospray/mass spectrometry. The confirmatory procedure was successfully evaluated by one FDA laboratory.
美国食品药品监督管理局发起了一项实验室间研究,该研究采用液相色谱法并结合紫外检测,以测定鸡肝和肌肉组织中的尼卡巴嗪。该方法用于测定尼卡巴嗪中的4,4'-二硝基碳酰苯胺(DNC)部分。该测定方法的实验室间研究在4 ppm水平的尼卡巴嗪测定中取得了成功。结果表明,强化后的肝脏和肌肉样本具有良好的重现性。对于肌肉样本,在约4 ppm时,实验室间平均回收率和变异系数百分比分别为87.1%和10.9%;对于肝脏样本,分别为87.4%和7.5%。对给药后的肝脏和肌肉组织进行的实验室间分析得出的浓度水平与发起者获得的浓度水平相似。用于在纯化的组织提取物中鉴定DNC的确证程序采用了液相色谱 - 热喷雾/质谱法。一个美国食品药品监督管理局实验室成功评估了该确证程序。